tiprankstipranks
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
US Market

Aligos Therapeutics (ALGS) Income Statement

Compare
194 Followers

Aligos Therapeutics Income Statement

Last quarter (Q3 2024), Aligos Therapeutics's total revenue was $1.27M, a decrease of -60.82% from the same quarter last year. In Q3, Aligos Therapeutics's net income was $-19.26M. See Aligos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 15.53M$ 13.91M$ 4.36M$ 0.00$ 0.00
Gross Profit
$ 12.46M$ 10.23M$ -99.79M$ -3.33M$ -2.30M
Operating Expenses
$ 103.66M$ 111.49M$ 132.68M$ 97.83M$ 54.04M
Depreciation and Amortization
$ 3.07M$ 3.67M$ 3.78M$ 3.33M$ 2.30M
EBITDA
$ -85.06M$ -93.91M$ -124.54M$ -105.06M$ -49.88M
Operating Income
$ -88.13M$ -97.58M$ -128.32M$ -97.83M$ -54.04M
Other Income/Expenses
$ 1.24M$ 1.64M$ 132.00K$ -10.55M$ 1.86M
Pretax Income
$ -86.88M$ -95.94M$ -128.19M$ -108.38M$ -52.18M
Net Income
$ -87.68M$ -96.05M$ -128.33M$ -108.54M$ -52.26M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.52$ -2.25$ -3.22$ -3.18$ -2.38
Diluted EPS
$ -3.52$ -2.25$ -3.22$ -3.18$ -2.38
Weighted Average Shares Outstanding
24.87M 42.70M 39.86M 34.18M 21.93M
Weighted Average Shares Outstanding (Diluted)
24.87M 42.70M 39.86M 34.18M 21.93M
Currency in USD

Aligos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis